Biochemical Failure, PSADT and Morbidity Rates
Those of us who have had a radical prostatectomy and then have our PSA return are experiencing what the industry calls a biochemical recurrence. As with all things prostate cancer, there is a lack of [...]
Provenge Advocacy Hits the News
Prostate Cancer advocates continue to press the FDA to approve Provenge by staging marches in Washington and Chicago as well as continuing to add their names to Malecare's Action Letter. The advocacy has even caught [...]
Life Insurance Premium Waivers
Those of us who have life insurance policies, either group or individual, may not be required to continue to pay the premiums! Many policies contain a waiver of premiums in case of disability. If you [...]
The Other Things That Are Important
Oncology professionals, PC doctors, nurses, physical therapists and administrators, take pride for those they cure or for those of us for whom they are able to provide a progression-free survival. Sometimes it isn't about only [...]
Some Thoughts from Wendy
Dollars -- public and private -- spent on one area, have, of course, been diverted FROM another. I join you in desperately wishing to see greater support for research and treatment of prostate cancer, but [...]
PROVENGE UPDATE – DEMAND A COMPASSIONATE USE PROGRAM
Dendreon Corp. has received great news from the FDA about their pending application for the approval of Provenge. STILL TIME TO SIGN PATIENT PETITION TO FDA FOR PROSTATE CANCER TREATMENT APPROVAL and Provengenow news-- Click [...]